Tarsus posts $194.6 million in XDEMVY sales, advances four-drug pipelineNov 3Quarterly updatelotilanerlotilaner ophthalmic solution
Tarsus posts record XDEMVY sales, raises guidance, moves to acquire AlkeusAug 6Quarterly updatelotilaner ophthalmic solutionTarsus Pharmaceuticals, Inc.